Cancer Science Institute of Singapore (CSI)

A Premier Centre for Cutting Edge Cancer Research.

A dynamic research institute encompassing basic and translational studies, devoted to understanding the pathogenesis and treatment of cancer
null

Congratulations to Dr. Sanda on his remarkable achievement!

CSI Singapore is proud to announce the promotion of Dr. Takaomi Sanda to Associate Professor.

  Read More

null

A/Prof Edward Chow was recently involved in this impactful study led by Prof Dean Ho.

Using AI, Research Team Discovers Optimal Regimen Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

  Read More

null

Recent Study by CSI Researchers Holds Promise for Improved Therapeutic Treatment of Tumours with Mutated p53.

  Read More

null

(Genome Biol, Mar 2020)

NanoVar: Accurate Characterization of Patients' Genomic Structural Variants Using Low-depth Nanopore Sequencing.

  Read More

null

(Theranostics, Feb 2020)

Targeting Microtubules Sensitizes Drug Resistant Lung Cancer Cells to Lysosomal Pathway Inhibitors.

  Read More

null

(Nat Commun, Mar 2020)

A Common MET Polymorphism Harnesses HER2 Signaling to Drive Aggressive Squamous Cell Carcinoma.

  Read More

Giving to CSI

You can help us to shape the next generation of innovative cancer research

null
Epigenetics in Cancer Symposium 2020
Learn More

Upcoming Events

null

7th NCIS Annual Research Meeting
22 July - 25 July 2020

  Read More

null

RNA Biology Symposium 2020
1 - 2 October 2020

  Read More